Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/26 17:47 | 7/2/26 | UTHR | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | 60 | S.dm | -320,773 | 562.69 | 0 | -570 | 680 | D | |||||||||||||||
7/2/26 16:32 | 7/2/26 | UTHR | Health | Drug | Pharmaceutical Preparations | Mahon Paul A | MD | O | EVP,GC | 6 | S.d | -27,951 | 561.26 | 0 | -50 | 45 | D | |||||||||||||||
6/23/26 16:34 | 6/22/26 | UTHR | Health | Drug | Pharmaceutical Preparations | Edgemond James | MD | O | CFO,TREA | 22 | S.dm | -123,457 | 564.38 | 0 | -219 | 19 | D | |||||||||||||||
5/13/26 16:31 | 5/12/26 | UTHR | Health | Drug | Pharmaceutical Preparations | Mesa Nilda | MD | D | 1 | S | -150 | 581.93 | 0 | 0 | 5 | D | ||||||||||||||||
4/24/26 16:31 | 4/24/26 | UTHR | Health | Drug | Pharmaceutical Preparations | Patusky Christopher | MD | D | 2 | S.d | -2,235 | 571.53 | 0 | -4 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |